Literature DB >> 6835204

N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase.

M W Kloss, G M Rosen, E J Rauckman.   

Abstract

Experiments were conducted to determine which microsomal enzymes are involved in the in vitro hepatic oxidative N-demethylation of cocaine to norcocaine, the first step in the biotransformation of cocaine to its ultimate hepatotoxic metabolite. Cocaine was found to undergo conversion to norcocaine by two alternate pathways, one involving only cytochrome P-450 and the other requiring both cytochrome P-450 and FAD-containing monooxygenase. In the first pathway, cocaine was directly N-demethylated to norcocaine by cytochrome P-450; this reaction was enhanced by phenobarbital induction and was inhibited by both n-octylamine and metyrapone. The second route was found to be a two-step reaction involving cocaine N-oxide as an intermediate. In this pathway, cocaine is first oxidized to cocaine N-oxide by FAD-containing monooxygenase, followed by a cytochrome P-450-catalyzed N-demethylation to norcocaine. This latter step was enhanced by phenobarbital treatment and inhibited by n-octylamine. Cocaine N-oxide also exhibited a Type I binding spectrum with mouse hepatic microsomes. In addition, a model system consisting of ferrous sulfate was found to catalyze the N-demethylation of cocaine N-oxide. On the basis of these experiments, it is concluded that cytochrome P-450 and FAD-containing monooxygenase participate in the initial oxidation of cocaine to norcocaine. We also propose a mechanism to account for the conversion of cocaine N-oxide to norcocaine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835204

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Remy L Brim; Kathleen R Noon; Gregory T Collins; Joseph Nichols; Diwahar Narasimhan; Roger K Sunahara; James H Woods
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

2.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

3.  Biotransformation of norcocaine to norcocaine nitroxide by rat brain microsomes.

Authors:  M W Kloss; G M Rosen; E J Rauckman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Citalopram enhances cocaine's subjective effects in rats.

Authors:  Paul L Soto; Takato Hiranita; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

5.  Characterization of differential cocaine metabolism in mouse and rat through metabolomics-guided metabolite profiling.

Authors:  Dan Yao; Xiaolei Shi; Lei Wang; Blake A Gosnell; Chi Chen
Journal:  Drug Metab Dispos       Date:  2012-10-03       Impact factor: 3.922

6.  Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity.

Authors:  Xiaolei Shi; Dan Yao; Blake A Gosnell; Chi Chen
Journal:  J Lipid Res       Date:  2012-08-19       Impact factor: 5.922

Review 7.  Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites.

Authors:  U A Boelsterli; C Göldlin
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

8.  Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.

Authors:  Sharon L Walsh; William W Stoops; David E Moody; Shen-Nan Lin; George E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.157

9.  Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

Authors:  Martin J Hicks; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Suzette M Evans; Richard W Foltin; David M Andrenyak; David E Moody; George F Koob; Kim D Janda; Rodolfo J Ricart Arbona; Michelle L Lepherd; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-03       Impact factor: 5.032

10.  Synthesis and Biological Evaluation of [18F]FECNT-d4 as a Novel PET Agent for Dopamine Transporter Imaging.

Authors:  Shanshan Cao; Jie Tang; Chunyi Liu; Yi Fang; Linyang Ji; Yingjiao Xu; Zhengping Chen
Journal:  Mol Imaging Biol       Date:  2021-04-13       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.